Ticker Details
Erasca, Inc.
IPO Date:	July 16, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.72B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.21 | 3.76%
Avg Daily Range (30 D):	$0.46 | 7.03%
Avg Daily Range (90 D):	$0.22 | 4.82%

Institutional Daily Volume
Avg Daily Volume:	1.06M
Avg Daily Volume (30 D):	6.75M
Avg Daily Volume (90 D):	3.52M

Trade Size
Avg Trade Size (Sh.):	141
Avg Trade Size (Sh.) (30 D):	153
Avg Trade Size (Sh.) (90 D):	158

Institutional Trades
Total Institutional Trades:	604
Avg Institutional Trade:	$1.88M
Avg Institutional Trade (30 D):	$1.81M
Avg Institutional Trade (90 D):	$1.64M
Avg Institutional Trade Volume:	.39M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.76M
Avg Closing Trade (30 D):	$3.35M
Avg Closing Trade (90 D):	$2.68M
Avg Closing Volume:	539.65K

News

Jan 26, 2026 @ 12:52 PM Why Is Cancer Drug Developer Erasca Stock Trading ... Source: Vandana Singh

Jan 23, 2026 @ 9:01 PM Erasca Announces Closing of Upsized Public Offerin... Source: Globe Newswire

Jan 22, 2026 @ 1:54 AM Erasca Announces Pricing of Upsized Public Offerin... Source: Na

Jan 14, 2026 @ 3:52 PM Precision Killers: Why Big Pharma is Betting Billi... Source: Prnewswire

Aug 13, 2025 @ 2:16 AM Erasca Narrows Loss 46% in Fiscal Q2 Source: Na

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.43	$-.11	$-.12
Diluted EPS	$-.43	$-.11	$-.12
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-127.69M	$-30.61M	$-33.88M
Operating Income / Loss	$-144.01M	$-34.55M	$-38.13M
Cost of Revenue
Net Cash Flow	$1.35M	$4.09M	$-4.34M
PE Ratio